Search All Tech Briefings

Search technology briefings produced by NIHR Innovation Observatory. These are short reports on new or repurposed medicines that we have already sent to our stakeholders. Only those technologies (medicines) that are within the scope of our stakeholders will have a technology briefing available. Search our technology briefings by intervention (drug or device), specific indication (disease or condition), or general therapeutic area.

| 1184 Results

Clear All Filters

Title	Intervention	Indication	Therapeutic Area	Year	Actions
Talquetamab for previously treated relapsed or refractory multiple myeloma	Talquetamab	Multiple myeloma (MM)	Haematological Cancer and Lymphomas	2022	View \| Download
Talimogene laherparepvec in addition to pembrolizumab for metastatic melanoma	Pembrolizumab (Keytruda; MK-3475) , Talimogene laherparepvec (Imlygic; T-Vec)	Melanoma	Skin Cancer	2020	View \| Download
Talazoparib with enzalutamide for previously untreated homologous recombination repair-mutated metastatic hormonal-sensitive prostate cancer	Enzalutamide (Xtandi; MDV3100) , Talazoparib (MDV3800; BMN-673; Talzenna; talazoparib tosylate)	Prostate cancer	Male Reproductive Cancer	2024	View \| Download
Talazoparib in addition to enzalutamide for metastatic castration-resistant prostate cancer	Enzalutamide (Xtandi; MDV3100) , Talazoparib (MDV3800; BMN-673; Talzenna; talazoparib tosylate)	Prostate cancer	Male Reproductive Cancer	2021	View \| Download
Tagraxofusp for blastic plasmacytoid dendritic cell neoplasm	Tagraxofusp (Elzonris; SL-401)	Blastic plasmacytoid dendritic cell neoplasm (BPDCN)	Haematological Cancer and Lymphomas	2018	View \| Download
Tafasitamab with lenalidomide as add-on therapy for previously treated follicular lymphoma or marginal zone lymphoma	Lenalidomide (Revlimid) , Tafasitamab (MOR208; Monjuvi)	Follicular lymphoma , Marginal zone lymphoma (MZL)	Haematological Cancer and Lymphomas	2023	View \| Download
Tafasitamab in combination with lenalidomide for treating relapsed or refractory diffuse large B-cell lymphoma	Tafasitamab (MOR208; Monjuvi)	Diffuse large B-cell lymphoma (DLBCL)	Haematological Cancer and Lymphomas	2020	View \| Download
Tafamidis for Transthyretin Amyloid Cardiomyopathy	Tafamidis meglumine (Vyndaqel; Fx-1006A; PF-06291826)	Transthyretin amyloid cardiomyopathy	Cardiovascular System	2018	View \| Download
Tabelecleucel for Epstein-Barr Virus-associated lymphoproliferative disease following solid organ transplant	Tabelecleucel (Tab-cel; ATA129)	Post-transplant lymphoproliferative disease (PTLD)	Haematological Cancer and Lymphomas	2019	View \| Download
Synthetic hypericin (SGX301; VIMRxyn) for cutaneous T‐cell lymphoma, unspecified	Hypericin (SGX301; HBP-347)	Cutaneous T-cell lymphoma (CTCL)	Haematological Cancer and Lymphomas	2017	View \| Download